A carregar...
Structural Dynamics Behind Clinical Mutants of PncA-Asp12Ala, Pro54Leu, and His57Pro of Mycobacterium tuberculosis Associated With Pyrazinamide Resistance
Pyrazinamide (PZA) is one of the main FDA approved drugs to be used as the first line of defense against Mycobacterium Tuberculosis (MTB). It is activated into pyrazinoic acid (POA) via MTB's pncA gene-encoded pyrazinamidase (PZase). Mutations are most commonly responsible for PZA-resistance in...
Na minha lista:
| Publicado no: | Front Bioeng Biotechnol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6914729/ https://ncbi.nlm.nih.gov/pubmed/31921809 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fbioe.2019.00404 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|